In vitro study shows P2Y12 inhibitor killed antibiotic-resistant Gram-positive bacteria
The P2Y12 inhibitor ticagrelor (Brilinta) was found to have antibacterial properties against multi-drug resistant staphylococci and enterococci, researchers found.